TP53 and invasive carcinoma: In addition, high-grade PanIN without invasive carcinoma may be biologically different from high-grade PanIN with associated PDAC because of the low rates of TP53 and SMAD4 mutations in high-grade PanIN without invasive PDAC (11.8% and 0%, respectively).